Clinical evaluation of homoeopathic medicines in lipoproteinaemia

 

 

Objectives: The objectives of this study were to evolve a group of efficacious homoeopathic medicines in treatment of lipoproteinaemia, identify their reliable indications, most useful potencies, frequency of administration and relationship with other medicines.

 

Methods: Three hundred and twenty two patients with lipoproteinaemia and various clinical presentations were studied at Regional Research Institute (H), New Delhi, during the period 1992–2003. Cases of more than 30 years of age, with cholesterol > 200mg/100ml, triglycerides > 170mg/100ml, LDL > 150mg/100 ml and VLDL > 50mg/100ml were included in the study. Maximum cases (n=63) belonged to age group of 40-45 years). Specific parameters were followed to assess the intensity of complaints and the improvement status.  Homoeopathic medicines were prescribed in different potencies (Q to 10M), basing on the presenting complaints, mental and physical attributes of the patients. The patients were advised to have low calorie diet and regular exercise.

 

Results: Two hundred ninety three cases were followed up regularly and varying degrees of improvement were observed, viz. marked improvement in 77cases, moderate improvement in 113 cases, mild improvement in 100 cases and no improvement in 03 cases. Lycopodium (n=45), Calcarea carbonica (n=31), Pulsatilla (n=29), Rhus tox. (n=13) and Sulphur (n=13) in different potencies were the most effective medicines.

 

Conclusion: Results showed that homoeopathic medicines along with general management relieved the clinico-pathological findings and restored the general health of the patients having lipoproteinaemia. The objectives of the study to identify a group of effective medicines and their reliable indications were achieved but the other objectives could not be fulfilled. A further study based on high quality laboratory parameters and statistical tools is suggested for scientific validation.

 

 

Key words- observational study; homoeopathy; lipoproteinaemia; CCRH; India

 

J.P.Govekar, V.K.Paul

Regional Research Institute (H), New Delhi